Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,192 | 514 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,765 | 113 | $0 (2024) |
| PFIZER INC. | $843.45 | 52 | $0 (2024) |
| Lilly USA, LLC | $837.02 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $611.30 | 30 | $0 (2024) |
| Novo Nordisk Inc | $495.90 | 33 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $473.37 | 25 | $0 (2024) |
| Dexcom, Inc. | $412.26 | 18 | $0 (2024) |
| Amgen Inc. | $380.94 | 24 | $0 (2024) |
| PREVENTRIC DIAGNOSTICS, INC. | $374.10 | 3 | $0 (2022) |
| Abbott Laboratories | $369.05 | 10 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,198 | 119 | ABBVIE INC. ($315.08) |
| 2023 | $2,357 | 123 | ABBVIE INC. ($595.95) |
| 2022 | $2,421 | 119 | ABBVIE INC. ($418.04) |
| 2021 | $2,217 | 153 | AbbVie Inc. ($435.85) |
All Payment Transactions
514 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.40 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/16/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: VACCINES | ||||||
| 12/13/2024 | AstraZeneca Pharmaceuticals LP | NEXIUM (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Gastrointestinal | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.08 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: PAIN | ||||||
| 12/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: Obesity | ||||||
| 11/27/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $31.48 | General |
| Category: Psychology/Psychiatric | ||||||
| 11/22/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.58 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Oncology | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $22.46 | General |
| Category: VACCINES | ||||||
| 11/01/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Inflammation | ||||||
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.25 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/25/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Bone Health | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.03 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 465 | 624 | $90,903 | $27,856 |
| 2022 | 12 | 461 | 687 | $88,616 | $26,738 |
| 2021 | 13 | 455 | 687 | $93,978 | $28,799 |
| 2020 | 13 | 408 | 531 | $66,383 | $19,563 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 107 | 222 | $53,280 | $13,813 | 25.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 18 | 18 | $7,128 | $4,799 | 67.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 46 | 46 | $11,040 | $4,775 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 20 | 22 | $3,410 | $1,063 | 31.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 40 | 43 | $2,795 | $564.16 | 20.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $630.00 | $525.06 | 83.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 11 | 11 | $2,530 | $471.04 | 18.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 12 | 12 | $600.00 | $350.04 | 58.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 18 | 34 | $2,210 | $295.12 | 13.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 25 | 35 | $700.00 | $285.60 | 40.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 33 | 33 | $1,980 | $238.94 | 12.1% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 30 | 33 | $1,617 | $201.63 | 12.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 15 | 18 | $1,154 | $162.68 | 14.1% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 11 | 11 | $605.00 | $161.81 | 26.7% |
| 81003 | Automated urinalysis test | Office | 2023 | 61 | 68 | $1,224 | $149.60 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 116 | 243 | $58,320 | $16,993 | 29.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 41 | 41 | $9,840 | $4,461 | 45.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 20 | 20 | $1,580 | $1,371 | 86.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 24 | 27 | $4,185 | $1,173 | 28.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 24 | 25 | $1,250 | $702.14 | 56.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 41 | 44 | $2,860 | $569.08 | 19.9% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 19 | 39 | $2,535 | $373.97 | 14.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 34 | 36 | $2,160 | $291.03 | 13.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 58 | 99 | $1,980 | $290.46 | 14.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 23 | $1,449 | $208.04 | 14.4% |
About William Davis
William Davis is a Physician Assistant healthcare provider based in Fayetteville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/23/2019. The National Provider Identifier (NPI) number assigned to this provider is 1598229676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, William Davis has received a total of $9,192 in payments from pharmaceutical and medical device companies, with $2,198 received in 2024. These payments were reported across 514 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($9,192).
As a Medicare-enrolled provider, Davis has provided services to 1,789 Medicare beneficiaries, totaling 2,529 services with total Medicare billing of $102,956. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Fayetteville, NC
- Active Since 01/23/2019
- Last Updated 01/23/2019
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1598229676
Products in Payments
- VRAYLAR (Drug) $1,060
- XIFAXAN (Drug) $454.97
- BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM (Device) $374.10
- TRULICITY (Drug) $333.30
- ELIQUIS (Drug) $330.51
- Dexcom G6 Transmitter (Medical Supply) $325.30
- NURTEC ODT (Drug) $324.84
- FREESTYLE LIBRE 3 (Device) $323.62
- Kerendia (Drug) $314.12
- FARXIGA (Drug) $306.59
- UBRELVY (Drug) $297.25
- EMGALITY (Drug) $262.88
- TRINTELLIX (Drug) $254.42
- QULIPTA (Drug) $214.68
- REXULTI (Drug) $210.71
- Ozempic (Drug) $186.75
- Rybelsus (Drug) $161.31
- PREVNAR 20 (Biological) $156.34
- Otezla (Drug) $151.92
- Aimovig (Biological) $138.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Fayetteville
Peter Kalogerinis, Pa-C, PA-C
Physician Assistant — Payments: $72,155
Mr. William Cotton, Pa-C, PA-C
Physician Assistant — Payments: $6,861
Emily Townsend, Pa-C, PA-C
Physician Assistant — Payments: $6,735
Thomas Daignault, Pa, PA
Physician Assistant — Payments: $5,954
Daniel Green
Physician Assistant — Payments: $5,626
Mr. Joshua Matthews, Pa-C, PA-C
Physician Assistant — Payments: $5,342